Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
JAMA Ophthalmol
; 140(7): 692-698, 2022 07 01.
Article
in En
| MEDLINE
| ID: mdl-35653117
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fatty Acids, Omega-3
/
Lung Neoplasms
/
Macular Degeneration
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
Language:
En
Journal:
JAMA Ophthalmol
Year:
2022
Document type:
Article
Country of publication:
United States